510(k) Report

510(k) · Cleared

Recalled · Class II · 2023

Sensus Healthcare Superficial X-ray Radiation Therapy System with Ultrasonic Imaging Capabilities

K150037510(k) TraditionalCleared Oct 16, 2015280-day reviewClass II21 CFR 892.5900Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sensus Healthcare · JAD System, Therapeutic, X-Ray

Cleared on Oct 16, 2015 as substantially equivalent to K131582 (Sensus Healthcare, 2013) after a 280-day review. Its family tree reaches back 4 generations to 1996. 3 later devices descend from it. It has been recalled once.

Decided
Oct 16, 2015
Review
280 days
Class
Class II
Product code
JAD
Recalls
1
Predicates
1

Its longest line of descent runs back 4 generations to K962613 (1996). 5 ancestors in all. 3 later devices descend from it, 3 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1997: 1 other ancestor2018: 1 descendant cleared2025: 1 descendant cleared2022: 1 descendant clearedReference device: K983945 · Cortex Dermascan C Ultrasonic System · Cortex Technology Aps · 1999Reference device: K132092 · Esteya · Nucletron B.V. · 2013K962613 · Darpac 2000 Superficial X-Ray Therapy System · Gulmay Medical, Ltd. · 1996 · recalledK063456 · SRT100 Superficial Radiation Therapy System · Topex, Inc. · 2007×2: 2 generations cleared close together, K123985 (2013), K131582 (2013) 1995200020052010201520202025
  1. Root · 4 generations backK962613 Darpac 2000 Superficial X-Ray Therapy SystemGulmay Medical, Ltd. · 1996 · Recalled
  2. 3 generations backK063456 SRT100 Superficial Radiation Therapy SystemTopex, Inc. · 2007
  3. 2 generations backK123985 Sensus Healthcare Superficial Radiotherapy System SRT-100Sensus Healthcare · 2013
  4. 1 generation backK131582 Sensus Helthcare Image-Duided Superficial Radiotherapy SystemSensus Healthcare · 2013
  5. This deviceK150037 Sensus Healthcare Superficial X-ray Radiation Therapy System with…Sensus Healthcare · 2015
  6. Descendant · cites it directly · 0 of its ownK250692 GentleBeam (GB1000)Voxel Ray Solutions, LLC · 2025
  7. Descendant · cites it directly · 0 of its ownK213942 EsteyaNucletron B.V. · 2022
  8. Descendant · cites it directly · 0 of its ownK173425 SRT-100+Sensus Healthcare, Inc. · 2018

Most influential descendants

Showing 3 of 3 · See all
  • K250692GentleBeam (GB1000)Voxel Ray Solutions, LLC · 2025 · cites it directly0descendants
  • K213942EsteyaNucletron B.V. · 2022 · cites it directly0descendants
  • K173425SRT-100+Sensus Healthcare, Inc. · 2018 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K962613Darpac 2000 Superficial X-Ray Therapy SystemGulmay Medical, Ltd.19962
−3K063456SRT100 Superficial Radiation Therapy SystemTopex, Inc.2007—
−2K123985Sensus Healthcare Superficial Radiotherapy System SRT-100Sensus Healthcare2013—
−1K131582Sensus Helthcare Image-Duided Superficial Radiotherapy SystemSensus Healthcare2013—
0 (this device)K150037Sensus Healthcare Superficial X-ray Radiation Therapy System with Ultrasonic…Sensus Healthcare2015—
+1K250692GentleBeam (GB1000)Voxel Ray Solutions, LLC2025—
+1K213942EsteyaNucletron B.V.2022—
+1K173425SRT-100+Sensus Healthcare, Inc.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
202210
202510
FIG. 1 — Lineage of K150037, 1996–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAD device

  1. #1 K241174 INTRABEAM (700); And accessories (INTRABEAM…score 11.7 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K131582Sensus Helthcare Image-Duided Superficial Radiotherapy System
Summary page 4
…ss II Product Code: JAD Regulation Number: 892.5900 Predicate Device: Sensus Healthcare SRT-100 Vision (K131582) Section 5 – 510(k) Summary (Sensus Healthcare SRT-100 Vision) 5-1 Reference D…
Sensus Healthcare2013—
†K983945Cortex Dermascan C Ultrasonic SystemCortex Technology Aps1999—
†K132092EsteyaNucletron B.V.2013—

What descends from it? (3)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K250692GentleBeam (GB1000)Voxel Ray Solutions, LLC20250
K213942EsteyaNucletron B.V.20220
K173425SRT-100+Sensus Healthcare, Inc.20180

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Feb 10, 2023Class IIZ-1235-2023Software designWhen the user pauses the beam delivery, the dose timer is reset (to zero), and as a result may deliver an unexpected dose to the patient.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 3 companies; a new generation was cleared every 6.3 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • Of its descendants, K250692 (Voxel Ray Solutions, LLC, 2025) has gone furthest, with 0 descendants of its own.

How does its category compare?

All JAD devices

JAD System, Therapeutic, X-Ray: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · JAD

2in 2025

2007: 12008: 22009: 32011: 12012: 22013: 52014: 12015: 12016: 22017: 12018: 12019: 22022: 12023: 12025: 2
2007high 5 (2013) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAD

114in 2013

2009: 106 days median2013: 114 days median
2007high 114 (2013) · low 106 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAD

2in 2021

2009: 22011: 12012: 32017: 12021: 22026 (partial year): 1
2007high 3 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAD

1in 2025

2007: 22008: 22009: 52011: 32012: 42013: 122014: 42015: 52016: 52017: 32018: 12019: 92022: 52023: 22024: 52025: 1
2007high 12 (2013) · low 0 (2010)2025

MAUDE reports naming product code JAD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—02
20082—02
2009310625
20100—00
20111—13
20122—34
20135114012
20141—04
20151—05
20162—05
20171—13
20181—01
20192—09
20200—00
20210—20
20221—05
20231—02
20240—05
20252—01
20260—1—

What is it indicated for?

The SRT-100 Vision System is a low energy x-ray system, with ultrasound imaging capability, intended for superficial radiotherapy and electronic brachytherapy treatments of primary malignant epithelial neoplasms of the skin and keloids. Applications include: (a) basal cell carcinoma; (b) squamous cell carcinoma; (c) Metatypic carcinoma; (d) cutaneous appendage carcinoma (¢) Kaposi’s Sarcoma; and (f) the treatment of keloids. Keloids are benign fibrous…

Read the full statement (165 words)

The SRT-100 Vision System is a low energy x-ray system, with ultrasound imaging capability, intended for superficial radiotherapy and electronic brachytherapy treatments of primary malignant epithelial neoplasms of the skin and keloids. Applications include: (a) basal cell carcinoma; (b) squamous cell carcinoma; (c) Metatypic carcinoma; (d) cutaneous appendage carcinoma (¢) Kaposi’s Sarcoma; and (f) the treatment of keloids. Keloids are benign fibrous growths that arise from proliferation of dermal tissue typically arising from injuries to skin tissue.

The ultrasound capability, employed in a non-diagnostic mode, is used to assist the physician in the selection of the correct cone applicator size. The Derma-Scan C Ultrasound component was initially cleared with an indication for use as an ultrasonic scanning system used to visualize the layers of skin, including bold vessels, and to make approximate measurements of dimensions in layers of skin and blood vessels, by ultrasonic means.

The red-diode laser assembly is a commercial pointer device employed by physicians for improving the alignment of the focused beam.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K150037: Sensus Healthcare Superficial X-ray Radiation Therapy System with Ultrasonic Imaging Capabilities.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K150037

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026